Scarica l'app Stockscreener
124.82
3.12%
3.78
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RVTY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$121.04
Aprire:
$122.54
Volume 24 ore:
2.29M
Relative Volume:
3.41
Capitalizzazione di mercato:
$15.39B
Reddito:
$2.71B
Utile/perdita netta:
$169.43M
Rapporto P/E:
20.99
EPS:
5.9463
Flusso di cassa netto:
$382.96M
1 W Prestazione:
+6.24%
1M Prestazione:
+0.69%
6M Prestazione:
+24.06%
1 anno Prestazione:
+41.58%
Intervallo 1D:
$120.75
$128.83
Intervallo di 1 settimana:
$116.39
$128.83
Portata 52W:
$82.17
$128.83
Revvity Inc Stock (RVTY) Company Profile
Nome
Revvity Inc
Settore
Industria
Telefono
781-663-5791
Indirizzo
940 WINTER STREET, WALTHAM
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-01-16 | Downgrade | UBS | Buy → Neutral |
| 2024-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-05-23 | Ripresa | Goldman | Buy |
Mostra tutto
Revvity Inc Borsa (RVTY) Ultime notizie
Revvity Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Revvity Inc (RVTY) Q3 2024 Earnings Call Highlights: Strong EPS and Cash Flow Amid Market Challenges - GuruFocus.com
Q3 2024 Revvity Inc Earnings Call - Mujer es Más
Revvity Reports Strong Q3 Growth and New Share Buyback - TipRanks
Earnings call: Revitty reports solid Q3 with $684 million in revenue - Investing.com
Revvity (NYSE:RVTY) Hits New 52-Week HighHere's Why - MarketBeat
KeyBanc maintains $132 target on Revvity amid EPS guidance raise By Investing.com - Investing.com UK
RVTY Q3 Earnings & Revenues Beat Estimates, Guidance Revised - MSN
Revvity Inc price target raised to $134 by Evercore ISI - Investing.com India
Revvity Inc (RVTY) Shares Up 5.6% on Nov 4 - GuruFocus.com
Developing image-based T-cell assays for monitoring apoptosis and CAR expression - News-Medical.Net
Revvity climbs after raising 2024 profit forecast - XM
Here's What Key Metrics Tell Us About Revvity (RVTY) Q3 Earnings - Yahoo Finance
Revvity Adjusts Revenue Forecast But Lifts Profit Expectations - Finimize
Revvity cuts 2024 revenue forecast amid biotech spending slowdown - Reuters
Revvity Inc (RVTY) Q3 2024 Earnings: Revenue Hits $684M, GAAP EPS Soars to $0.77, Surpassing Estimates - GuruFocus.com
Revvity (RVTY) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance
Revvity: Q3 Earnings Snapshot - San Antonio Express-News
Revvity Q3 24 Earnings Conference Call At 8:00 AM ET - Nasdaq
Revvity beats Q3 expectations, raises full-year EPS outlook By Investing.com - Investing.com Australia
Revvity earnings beat by $0.15, revenue topped estimates - Investing.com Canada
Revvity, Inc. Q3 Profit Increases, Beats Estimates - Nasdaq
Revvity, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 29, 2024 - Marketscreener.com
International Assets Investment Management LLC Raises Holdings in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Coronation Fund Managers Ltd. Has $11.85 Million Stock Holdings in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Ceredex Value Advisors LLC Has $101.07 Million Stock Holdings in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity to Report Q3 Earnings: What's in Store for the Stock? - MSN
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Revvity, Inc. (NYSE:RVTY) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Revvity Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Assenagon Asset Management S.A. Trims Stock Holdings in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories - Technology Networks
Bay Colony Advisory Group Inc d b a Bay Colony Advisors Buys Shares of 7,696 Revvity, Inc. (NYSE:RVTY) - MarketBeat
Earnings Preview: Revvity (RVTY) Q3 Earnings Expected to Decline - Yahoo Finance
Revvity Board Declares Quarterly Dividend - 01Net
Revvity Earnings Preview: What to Expect - MSN
Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch
Revvity, Inc. Declares Quarterly Dividend of $0.07 (NYSE:RVTY) - MarketBeat
Here's Why Revvity (NYSE:RVTY) Can Manage Its Debt Responsibly - Simply Wall St
Infectious Disease Diagnostics Market to Reach USD 43.09 Billion by 2031 | SkyQuest Technology - Benzinga
Zacks Research Issues Negative Outlook for Revvity Earnings - MarketBeat
Revvity Shares Decline Despite Launch of Transcribe AI Solution - MSN
Revvity launches AI to digitize handwritten lab forms - Investing.com
Revvity launches AI to digitize handwritten lab forms By Investing.com - Investing.com UK
Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report - Business Wire
CRISPR-based Gene Editing Market Report 2024-2030, - GlobeNewswire
CRISPR-based Gene Editing Market Report 2024-2030, Featuring Revvity, Danaher, GenScript, Merck, Tocris Bioscience, OriGene Technologies, Bio-Rad Laboratories, Bio-Techne & New England Biolabs - Yahoo Finance
Revvity Earnings Preview: What To Expect - Barchart
Revvity Inc Azioni (RVTY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.73%
0.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):